In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent is better perceived by patients, the fragmented technology landscape sites have to navigate, the plain-language and health-literacy challenges baked into consent forms, and the timeline and budget pressures that keep eConsent from being standard practice. They also cover why pediatric and rare disease studies could be the fastest path to wider adoption, and how reconsent, an often-overlooked, recurring part of the process, is particularly well suited to going digital.
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd...
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant...
In this episode of LifeSci Talks, TransPerfect’s Global Practice Leader Mark Wade sits down with Dr. Karl McEvoy, VP of eCOA and Patient Technology...
